alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › perspectives

perspectives

5 studies tagged perspectives, dated 2014-06-16 to 2023-02-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity 2023-02-22
  2. PICALM and Alzheimer's Disease: An Update and Perspectives 2022-12-10
  3. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives 2022-03-14

Studies

5 studies carry this tag.

Date range

2014 to 2023

Top journals

  • Alzheimer's research & therapy 1
  • BioMed research international 1
  • Brain pathology (Zurich, Switzerland) 1
  • Cells 1
  • Current medicinal chemistry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Alzheimer's research & therapy 2023-02-22 Brain scans and imaging

    The site and rate of atrophy are different across the tau-PET patterns.

  2. PICALM and Alzheimer's Disease: An Update and Perspectives

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cells 2022-12-10 Genetics

    Genome-wide association studies (GWAS) have identified the PICALM (Phosphatidylinositol binding clathrin-assembly protein) gene as the most significant genetic susceptibility locus after APOE and BIN1 .

  3. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain pathology (Zurich, Switzerland) 2022-03-14 Genetics

    Cerebrovascular disease underpins vascular dementia (VaD), but structural and functional changes to the cerebral vasculature contribute to disease pathology and cognitive decline in Alzheimer's disease (AD).

  4. Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Current medicinal chemistry 2018-01-01 Tau biomarkers

    Dementia is characterized by the impairment of cognition and behavior of people over 65 years.

  5. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BioMed research international 2014-06-16 Biomarkers

    Chronic neuroinflammation is now considered one of the major factors in the pathogenesis of Alzheimer's disease (AD).

All topic tags with their study counts